Validation of Nanosensor Oxygen Measurement

Abroad (travel likely)RecruitingPHASE1

Conditions

MItochondrial Myopathies · Mitochondrial Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Zarazuela Zolkipli-Cunningham, MBChB, MRCP) · MitoMyopathyResearch@chop.edu · 267-426-1986
Contact: Study coordinator (Daniel McGinn, MS, LCGC) · MitoMyopathyResearch@chop.edu · (267) 426-1986
Contact: Principal Investigator (Zarazuela Zolkipli-Cunningham, MBChB, MRCP)

Study leads

Zarazuela Zolkipli-Cunningham, MBChB, MRCP
Principal Investigator
Children's Hospital of Philadelphia

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Validation of Oxygen Nanosensor in Mitochondrial Myopathy

Mitochondrial Myopathies · Mitochondrial Diseases

Abroad (travel likely)RecruitingPHASE1

Philadelphia, United States

Applying pGz in Mitochondrial Disease

Mitochondrial Myopathies · Mitochondrial Diseases

Abroad (travel likely)RecruitingPHASE1

Philadelphia, United States

Global Registry and Natural History Study for Mitochondrial Disorders

Mitochondrial Diseases · Kearns-Sayre Syndrome · MIDD

Abroad (travel likely)Recruiting

Innsbruck, Austria · Salzburg, Austria

Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels

Mitochondrial Disease

Abroad (travel likely)RecruitingPHASE1

New York, United States